Systematic Review & Meta-Analysis (Pharma)

$35,000

PRISMA 2020 and Cochrane-compliant systematic review and meta-analysis for regulatory submissions, HTA dossiers, and evidence synthesis. PROSPERO registration, GRADE assessment, and publication-ready manuscript.

SKU: EV-MC-003 Category:

Description

<![CDATA[

Systematic Review & Meta-Analysis (Industry-Sponsored)

Comprehensive evidence synthesis supporting regulatory submissions, label claims, and health technology assessments. PRISMA 2020-compliant systematic reviews with quantitative meta-analysis.

Compliance Framework

  • PRISMA 2020 – Reporting guideline
  • Cochrane Handbook – Methodological standards
  • GRADE – Evidence quality assessment
  • GPP3 – Industry-sponsored review ethics
  • PROSPERO – Protocol registration

Deliverables

  • PROSPERO-registered protocol
  • Comprehensive search strategy (MEDLINE, Embase, Cochrane, etc.)
  • Study selection with PRISMA flow diagram
  • Data extraction tables
  • Risk of bias assessment (Cochrane RoB 2, ROBINS-I)
  • Meta-analysis with forest plots
  • Heterogeneity and sensitivity analyses
  • Publication bias assessment
  • GRADE evidence summary tables
  • Full manuscript (journal-ready)

Applications

  • Regulatory submission support (Module 2.5)
  • HTA dossiers
  • Label expansion evidence
  • Competitive positioning
  • Guideline development support

Timeline

Standard: 16-24 weeks | Rapid review: 8-12 weeks

]]>